Modafinil for Night Shift Workers: The Trial Evidence and One Worker's Account
For modafinil for night shift workers, FDA approval concerns excessive sleepiness associated with shift-work disorder.12 In a three-month trial of 209 patients, 74 percent on modafinil had at least minimal symptom improvement versus 36 percent on placebo.12 My night-work experience taught me that feeling alert differed from being rested.
Personal account, not medical advice. Modafinil is a prescription medicine, and a Schedule IV controlled substance in the United States. Nothing here is a recommendation to start, stop or change anything. Talk to a doctor.
What the shift-work trial found
The trial ran for three months. It took 209 patients who had been diagnosed with shift-work sleep disorder and randomly assigned them, double-blind, to modafinil or placebo before the start of each shift, with monthly assessments.1 The measurements were broad: the nighttime Multiple Sleep Latency Test, the Clinical Global Impression of Change, the Psychomotor Vigilance Test, patient diaries and daytime sleep monitoring, so the trial reported results on several measures, not just one.1
Three results stand out from the published account of the trial.1
- More patients on modafinil had at least minimal improvement in symptoms at three months: 74 percent against 36 percent on placebo.12
- Attention lapses during nighttime testing went down on modafinil, both in frequency and in duration, and proportionally fewer patients reported having had accidents or near accidents while commuting home: 29 percent against 54 percent.1
- Daytime sleep was not worse on modafinil: the paper's own line is that modafinil "did not adversely affect daytime sleep as compared with placebo."1
Patients treated with modafinil still had excessive sleepiness and impaired performance at night.1 These results do not establish that driving tired on modafinil is safe.
On the nighttime Multiple Sleep Latency Test, sleep latency (the interval between the time a person attempts to fall asleep and the onset of sleep) lengthened by 1.7 minutes on modafinil against 0.3 on placebo, and the authors called that "a modest improvement from baseline".1 For performance their word was different: treatment produced "a small but significant improvement in performance" as compared with placebo.1 On the Psychomotor Vigilance Test, attention-lapse frequency fell by 2.6 on treatment while rising by 3.8 on placebo.1
In the NEJM Clinician summary's terms, "74 percent" means at least minimal improvement in symptoms; it is not a measure of recovery.2 The paper's own summary is careful in the same way: treatment "reduced the extreme sleepiness that we observed in patients with shift-work sleep disorder", and the residual sleepiness "underscores the need for the development of interventions that are even more effective."1 Headache was the most common adverse event in the trial.1
The shift-work indication came later. Modafinil was approved initially to improve wakefulness in patients with narcolepsy, and obstructive sleep apnea and shift-work sleep disorder were added as indications afterwards; the shift-work approval was based partly on results from this industry-supported randomized trial.2
Shift-work disorder versus ordinary tiredness
For modafinil shift work disorder research, the definition is specific: the trial paper describes patients who "chronically have excessive sleepiness during night work and insomnia when attempting to sleep during the day."1 The NEJM Clinician summary of the trial says the participants "worked at least 5 night shifts monthly (with at least 3 shifts occurring consecutively)".2
The results belong to patients with that diagnosis. They do not establish the same benefit in night workers who carry ordinary tiredness after a run of nights and have no such diagnosis. The trial's numbers are attached to that definition: 74 percent against 36 percent, in patients who met it at the start.1
Night shifts on modafinil: one worker's account
My modafinil night shift use started with one aim: to stay alert until the shift ended. The work was in heavy industry, and there was no enhancement plan behind it. When a change of role ended the night work, I stopped needing it.
Alert isn't rested: the warning light
The belief that stuck with me from that time is mine, not a finding: on short sleep, modafinil masked tiredness while the sleep deficit kept building underneath. It hid the warning light without fixing the problem.
In my experience, feeling awake and being rested were two different states: the tiredness was hidden; the debt was still there.
The cost of trading sleep
The two modafinil sleep deprivation studies below come from military aviation, not shift work. Caldwell studied ten F-117 pilots during 37 hours of continuous wakefulness.3 Wingelaar-Jagt studied 32 Royal Netherlands Air Force volunteers after a median of 17 hours awake.4
The military research is blunt about the limit. The paper's stated purpose was to determine whether modafinil would attenuate the effects of fatigue on fighter-pilot mood and performance during 37 hours of continuous wakefulness.3 Overall, modafinil kept flight accuracy within roughly 15 to 30 percent of baseline, and it reduced the decline on six of eight simulator maneuvers. Under the placebo condition, performance fell by as much as 60 to 100 percent.3 The study's own conclusion notes that modafinil "did not sustain performance at predeprivation levels," and it suggests the drug be considered for the military's armament of short-term fatigue countermeasures.3 It narrowed the gap between sleep-deprived and rested; it did not close it.
The study itself was small and specific: "A quasi-experimental, single-blind, counterbalanced design" that tested modafinil in ten Air Force F-117 pilots, given at 17, 22 and 27 hours without sleep.3 Alongside the flight scores, the drug improved their self-rated vigor, alertness and confidence and lowered ratings of depression and anger, with the benefits most noticeable after 24 to 32 hours of continuous wakefulness.3
My own summary: five hours of sleep plus modafinil performed better than five hours without it, but worse than a full night's sleep with no modafinil.
What people get wrong about staying awake on it
The mistake is to read a vigilance result as a safety result. A later randomized trial in air force crewmembers who had been awake for a median of 17 hours assessed vigilance, performance and reported sleepiness during limited sleep deprivation, testing vigilance and tracking at points over the hours after a dose.4 It is not evidence that modafinil makes it safe to drive tired or to work through a shift.
That study compared modafinil, caffeine and placebo head to head, with the aim of measuring their effect on vigilance during a limited period of sleep deprivation.4 Both active drugs improved vigilance and performance against placebo, with statistically significant effects on all endpoints except one tracking measure, and both "resulted in a lower level of reported sleepiness after a limited period of sleep deprivation."4 Modafinil "was effective for longer than caffeine, which is consistent with its longer half-life."4 At eight hours after a dose, modafinil had significantly better scores than caffeine on the vigilance test and on the sleepiness scale.4
The design is worth knowing: 32 volunteers of the Royal Netherlands Air Force were given modafinil, caffeine and placebo on three non-consecutive days after a median of 17 hours awake, with neither the volunteers nor the researchers knowing which treatment was given.4 The study notes: "In 2010, for the first time in an air crash investigation, a recording of snoring was identified on a cockpit voice recorder."4
Questions the research on this page does not resolve
The research summarized on this page does not resolve how the first night compares with later nights or what happens in the hardest hours before dawn. The shift-work trial's own line is that modafinil "did not adversely affect daytime sleep as compared with placebo."1 That finding does not establish how any particular person would sleep after a shift.
Written by The Night Owl, a long-term user of modafinil who is not a doctor, pharmacist or healthcare provider. This page describes one person's experience alongside published research. It is not medical advice.
Sources
1: Czeisler C.A. et al. Modafinil for Excessive Sleepiness Associated with Shift-Work Sleep Disorder. New England Journal of Medicine. 2005. https://pubmed.ncbi.nlm.nih.gov/16079371/
2: Brett A.S. Modafinil for Shift-Work Sleep Disorder. NEJM Clinician. 2005. https://clinician.nejm.org/modafinil-shift-work-sleep-disorder-JP200510050000010
3: Caldwell J.A. et al. Modafinil's effects on simulator performance and mood in pilots during 37 h without sleep. Aviation, Space, and Environmental Medicine. 2004. https://pubmed.ncbi.nlm.nih.gov/15460629/
4: Wingelaar-Jagt Y.Q. et al. Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial. Journal of Psychopharmacology. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9912306/